Perspective Therapeutics CATX
NYSE CATX
$3.22 -0.26 (-7.47%)
At close: Aug 20, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Sales of Property, Plant and Equipment (2019)

Perspective Therapeutics (CATX) Sales of Property, Plant and Equipment (2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.14 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Perspective Therapeutics 389.10 Mn 389.10 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2019 10,000.00
Jun 30, 2019 10,000.00
Mar 31, 2019 1,000.00
Mar 31, 2019 1,000.00